$UL (Unilever PLC)

$UL {{ '2016-07-20T15:23:01+0000' | timeago}} • Announcement

$UL said its acquisition of Dollar Shave Club (DSC), which owns a repertoire of brands that range from personal wash products to daily wipes, will boost its personal care category in the men's segment. $UL said DSC CEO Michael Dubin will continue to serve as CEO of the company. DSC expects a turnover of $200MM in 2016, $UL said.

$PPG {{ '2018-01-18T16:01:15+0000' | timeago}} • Announcement

$PPG, a manufacturer of coatings, reported an 8% growth in sales to $3.7Bil in 4Q17, helped mainly by higher selling prices and favorable currency rates. Net earnings were $0.73 per share, compared to $1.31 per share in 4Q16, which included one-time gains. Adjusted for special items, 4Q17 earnings were $1.19 per share, up 3% from last year.

$CL {{ '2018-01-11T22:22:35+0000' | timeago}} • Announcement

$CL declared a quarterly cash dividend of $0.40 per common share, payable on February 15, 2018, to shareholders of record on January 23, 2018.

$DF {{ '2018-01-11T12:22:41+0000' | timeago}} • Announcement

Food and beverage company $DF appointed Jody Macedonio as EVP and COO, effective February 26, 2018. Macedonio, a veteran in the 'consumer packaged goods' industry, has been serving Henkel AG as SVP of Finance for the company's North America Laundry and Beauty Divisions. Earlier, he worked for Sun Products and PepsiCo in senior executive positions.

$PFE {{ '2018-01-04T13:11:11+0000' | timeago}} • Announcement

Arvinas LLC collaborates with $PFE for the discovery and development of drug candidates using Arvinas' PROTAC Platform, a novel technology used to create small molecule therapeutics aimed at degrading disease-causing cellular proteins. Arvinas may receive up to $830MM in upfront and potential development and commercialization milestone payments.

$JNJ {{ '2018-01-02T19:20:09+0000' | timeago}} • Announcement

$JNJ declared a cash dividend for 1Q18 of $0.84 per share on the company's common stock. The dividend is payable on March 13, 2018 to shareholders as on Feb 27, 2018.

$PFE {{ '2017-12-26T12:25:28+0000' | timeago}} • Announcement

$PFE and $MRK announced that the US FDA has approved STEGLATRO (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN (ertugliflozin and sitagliptin) tablets for adults with type 2 diabetes.

$CAG {{ '2017-12-22T18:27:34+0000' | timeago}} • Webcast

$CAG has been on a buying spree in order to strengthen its position, mainly in the snacks space. During 2Q18, it completed the $250MM acquisition of Angie's Artisan Treats, the maker of Angie's Boom Chicka Pop. The company also entered into an agreement to acquire Sandwich Bros. of Wisconsin business. The deal is expected to close in early FY18.

$MRK {{ '2017-12-22T16:34:34+0000' | timeago}} • Announcement

$MRK and $PFE announced that the FDA approved STEGLATROTM (ertugliflozin) tablets, an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor, and the fixed-dose combination STEGLUJAN (ertugliflozin and sitagliptin) tablets.

$PFE {{ '2017-12-21T21:14:41+0000' | timeago}} • Announcement

$PFE announced that the US FDA has granted Breakthrough Therapy Designation for avelumab in combination with INLYTA for treatment-naive patients with advanced renal cell carcinoma (RCC). This is the second Breakthrough Therapy Designation granted to avelumab.

$JNJ {{ '2017-12-21T18:10:50+0000' | timeago}} • Announcement

Janssen Biotech, a $JNJ company, said the FDA has granted Priority Review designation for the New Drug Application (NDA) for apalutamide as treatment for non-metastatic castration-resistant prostate cancer (CRPC). This is the first agent submitted for approval to treat earlier stage castration-resistant prostate cancer at high risk for metastasis.

$CAG {{ '2017-12-21T17:27:54+0000' | timeago}} • Announcement

$CAG agreed to acquire the Sandwich Bros. of Wisconsin business, which produces frozen breakfast and entree flatbread sandwiches. The transaction is expected to close in early 2018.

$CAG {{ '2017-12-21T16:37:54+0000' | timeago}} • Infographic

$CAG Conagra Brands, Inc. Earnings AlphaGraphic: Q2 2018 Highlights

$CAG {{ '2017-12-21T13:37:20+0000' | timeago}} • Announcement

For FY18, $CAG expects its organic net sales growth to be flat to down 2%. Adj. EPS from continuing operations is expected to be near the high end of the range of $1.84-1.89. Net sales growth is expected to be 100 to 150Bps higher than the organic net sales growth rate due to the impacts of acquisitions and foreign exchange.

$CAG {{ '2017-12-21T13:32:50+0000' | timeago}} • Announcement

$CAG reported 83% jump in its 2Q18 earnings, helped by net sales growth and lower interest expense. Net income grew to $223.5MM, or $0.54 per share, from $122.1MM, or $0.28 per share during 2Q17. Adj. EPS grew 12.2% from $0.49 to $0.55. Net sales rose 4% YoY to $2.17Bil, reflecting continued improvements in domestic retail volume growth.

$PFE {{ '2017-12-20T12:23:04+0000' | timeago}} • Announcement

The US FDA has approved $PFE's supplemental New Drug Application to expand the indication for BOSULIF  to include adult patients with newly-diagnosed chronic phase Philadelphia chromosome-positive chronic myelogenous leukemia (Ph CML).

$PFE {{ '2017-12-18T19:31:58+0000' | timeago}} • Announcement

The BoD of $PFE has increased the quarterly dividend by 6% to $0.34 per share. The first quarter 2018 cash dividend will be payable on March 1, 2018, to shareholders of record on Feb. 2, 2018. The board also authorized a new $10Bil share repurchase program, in addition to the $6.4Bil remaining under the current authorization.

$CL {{ '2017-12-18T12:57:15+0000' | timeago}} • Announcement

$CL agreed to purchase professional skin care brands PCA Skin and EltaMD in two separate transactions. The terms of the deals, currently expected to close in 1Q18, were undisclosed. These transactions are expected to have no impact on earnings in FY18.

$ALB {{ '2017-12-15T11:54:52+0000' | timeago}} • Announcement

Global specialty chemicals industry leader $ALB said it has signed a definitive agreement to sell its polyolefin catalysts and components business to $GRA in cash for approx. $416MM. The organometallics and curatives portions of the Performance Catalysts Solutions business will remain with $ALB. The deal is expected to close during 1Q18.

$PPG {{ '2017-12-15T11:25:04+0000' | timeago}} • Announcement

$PPG BoD authorized the repurchase of $2.5Bil of outstanding common stock effective immediately. This program is in addition to the company’s existing share repurchase authorization, which was approved in Oct. 2016 and had approx. $1.4Bil remaining as of Sept. 30, 2017.

$LLY {{ '2017-12-11T17:36:13+0000' | timeago}} • Announcement

FDA accepts to review $LLY's Galcanezumab, an injectionable drug for the treatment of migraine. Rivals $NVS and $AMGN already filed their migraine drug with FDA in July 2017, while $TEVA is also expected to join the race. Lilly's pain portfolio also includes Tanezumab, developed in partnership with $PFE, for the treatment of osteoarthritis.

Recent Transcripts

PPG (PPG Industries, Inc.)
Thursday, January 18 2018 - 7:00pm
CAG (ConAgra Foods, Inc.)
Thursday, December 21 2017 - 2:30pm
COTY (Coty Inc.)
Thursday, November 9 2017 - 5:00pm
DF (Dean Foods Company)
Tuesday, November 7 2017 - 2:00pm
REV (Revlon, Inc.)
Friday, November 3 2017 - 1:30pm
VGZ (Vista Gold Corp.)
Thursday, November 2 2017 - 8:30pm
SAND (Sandstorm Gold Ltd.)
Thursday, November 2 2017 - 3:00pm
MLM (Martin Marietta Materials, Inc.)
Thursday, November 2 2017 - 3:00pm
CHD (Church & Dwight Co. Inc.)
Thursday, November 2 2017 - 2:00pm
AVP (Avon Products Inc.)
Thursday, November 2 2017 - 12:30pm
CLX (The Clorox Company)
Wednesday, November 1 2017 - 5:30pm
EL (The Estée Lauder Companies Inc.)
Wednesday, November 1 2017 - 1:30pm
ECL (Ecolab Inc.)
Tuesday, October 31 2017 - 5:00pm
PFE (Pfizer Inc.)
Tuesday, October 31 2017 - 2:00pm
CL (Colgate-Palmolive Co.)
Friday, October 27 2017 - 3:00pm
TGB (Taseko Mines Ltd.)
Friday, October 27 2017 - 3:00pm
HSY (The Hershey Company)
Thursday, October 26 2017 - 12:30pm
SCL (Stepan Company)
Wednesday, October 25 2017 - 2:00pm
GRA (W.R. Grace & Co.)
Wednesday, October 25 2017 - 1:00pm
KO (The Coca-Cola Company)
Wednesday, October 25 2017 - 1:00pm

AlphaGraphics you may like